OKYO Pharma CMO Flavio Mantelli Buys 20,000 Shares

What Happened Flavio Mantelli, Chief Medical Officer of OKYO Pharma Ltd (OKYO), purchased 20,000 shares in an open-market transaction on July 21, 2026 at $1.40 per share, for a total cost of $28,000. This filing is an amendment (Form 4/A) submitted on August 7, 2026 to correct the transaction code associated with that purchase; no other transactions were changed.

Key Details

• Transaction date: 2026-07-21; Price: $1.40 per share; Shares purchased: 20,000; Total value: $28,000.
• Transaction type: Open-market purchase (code P). The amendment corrects the transaction code from the original Form 4 filed July 22, 2026.
• Shares owned after transaction: Not specified in this amendment (see the reported Form 4 for holdings).
• Filing: Amended Form 4/A filed 2026-08-07; original Form 4 filed 2026-07-22. Amendment only corrects the transaction code; no late-filing implication noted for the original report.

Context Purchases by company officers are often watched by investors as a sign of confidence, but filings only show the trade—no motive. This was a straightforward open-market buy (code P); there is no indication here of option exercises, gifts, or a 10b5-1 plan.